03 April 2024 | Wednesday | News
Dr. Funck brings a wealth of experience and expertise to his new role. Having studied business administration at the prestigious University of Münster, he further solidified his knowledge by earning his doctorate. His journey to this pivotal position has been marked by over two decades of remarkable contributions to the corporate world.
Prior to joining Sartorius, Dr. Funck held various leadership positions within the esteemed Haniel Group. Notably, he served as CFO of TAKKT AG, a publicly listed company in which Haniel holds a majority stake, from 2004 onwards. His tenure within the Haniel Group spanned from 1994 to 2023, during which he demonstrated exceptional financial acumen and strategic vision.
In his new capacity at Sartorius, Dr. Funck's responsibilities extend beyond finance. He will also oversee the Information Technology (IT) and central procurement functions, reflecting his diverse skill set and comprehensive understanding of organizational dynamics.
Dr. Funck's arrival heralds a new chapter for Sartorius, characterized by strengthened financial stewardship, innovative technological integration, and optimized procurement strategies. His proven track record and unwavering commitment to excellence make him an invaluable addition to the company's leadership team.
© 2025 Biopharma Boardroom. All Rights Reserved.